strategic alternatives

23andMe is exploring strategic alternatives, looking to raise capital

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year. 23andMe said it will "need additional liquidity" to fund its operations, and it is looking to raise additional capital.

Business Wire · 2d

Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “

Business Insider · 1d

Veradigm ends exploration of strategic alternatives without deal

Veradigm (MDRX) announced that its board of directors completed its previously announced review of strategic alternatives. “Throughout the

Seeking Alpha on MSN · 2d

Veradigm ends strategic review after no firm bids

Veradigm (OTC:MDRX) said that it's ending a strategic review after it received no firm proposals in its process. The electronic medical records firm disclosed that five bidders made preliminary, non-biding indications of interest,

Sage rejects Biogen’s buyout offer, but says it's open to deals

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Yahoo Finance6d

Novaturas will assess strategic alternatives

The analysis of strategic alternatives will include an assessment of various possible scenarios, including but not limited to raising additional capital or attracting a strategic investor ...

23andMe announces exploration of strategic alternatives

The Special Committee of the board of 23andMe Holding Co. announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a poss ...

The Business Journals4d

Genetic test maker 23andMe eyes strategic alternatives, including a sale

CEO Anne Wojcicki last spring proposed buying out the company and taking it private. Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said ...

Zacks.com on MSN12d

NGVT to Evaluate Strategic Alternatives for Industrial Specialties

Ingevity Corporation NGVT recently announced plans to explore strategic alternatives for its Performance Chemicals Industrial ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results